Literature DB >> 13651708

Beclamide in intractable epilepsy: a controlled trial.

J WILSON, J N WALTON, D J NEWELL.   

Abstract

Entities:  

Keywords:  ANTICONVULSANTS/therapeutic use; EPILEPSY/therapy

Mesh:

Substances:

Year:  1959        PMID: 13651708      PMCID: PMC1993459          DOI: 10.1136/bmj.1.5132.1275

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  Nydrane in the treatment of epilepsy.

Authors:  L R ROBINSON
Journal:  Br Med J       Date:  1957-05-11

2.  Effects of nydrane on epilepsy in mental defectives.

Authors:  D S SHARPE; G DUTTON; J R MIRREY
Journal:  Br Med J       Date:  1958-05-03

3.  Hibicon, a new anticonvulsant.

Authors:  J HOENIG; I M CROTTY; W R CHISHOLMBATTEN
Journal:  J Ment Sci       Date:  1956-01

4.  Hibicon in treatment of epileptics with mental disorder.

Authors:  D W MARTIN; S MERLIS
Journal:  Psychiatr Q       Date:  1956-07

5.  N-Benzyl-beta-chloropropionamide (hibicon); a new approach to anticonvulsant therapy.

Authors:  C D HAWKES
Journal:  AMA Arch Neurol Psychiatry       Date:  1952-06
  5 in total
  1 in total

1.  A simple method for the determination of beclamide in plasma by gas chromatography.

Authors:  O P Jones; H Leach; D K Luscombe; P J Nicholls
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.